TXG Kronos AI forecast
A 30-trading-day price forecast for 10x Genomics Inc. (TXG) from Kronos AI, an open-source foundation model trained on candlestick charts.
Kronos AI's median forecast puts 10x Genomics Inc. at $50.91 on 2026-12-08, −34.7% from the last close of $78.02 on 2026-10-27. Eight out of ten sampled paths end between $39.16 and $63.90, and 0 of the 8 paths finish above today's price.
Forecast path
median, with the 10–90% band of the sampled pathsOpen the interactive forecast → Full analysis of TXG
The forecast, week by week
| Date | Median | Low (10%) | High (90%) |
|---|---|---|---|
| 2026-11-03 | $71.47 | $66.04 | $75.34 |
| 2026-11-10 | $62.55 | $59.26 | $67.66 |
| 2026-11-17 | $53.56 | $49.62 | $59.06 |
| 2026-11-24 | $50.56 | $47.85 | $58.61 |
| 2026-12-01 | $51.27 | $43.21 | $60.70 |
| 2026-12-08 | $50.91 | $39.16 | $63.90 |
What is Kronos AI?
Kronos is an open-source foundation model for financial candlesticks, pre-trained on K-line data from more than 45 exchanges. Gnzub runs it on each stock's last 120 daily bars and samples several possible futures, so the forecast is a range of outcomes rather than one confident line. It is a statistical model, not an analyst: it reads price patterns only and knows nothing about news, earnings or the business.
Questions
- What is the Kronos AI forecast for TXG?
- Kronos AI's median forecast for TXG is $50.91 in 30 trading days, −34.7% from the last close, with a 10–90% range of $39.16 to $63.90.
- Is the TXG Kronos forecast a buy or sell signal?
- No. It is the output of a statistical model that reads price history only. It is not investment advice, and the range shows how uncertain the model is.
- How often is the forecast updated?
- The forecasts are regenerated regularly; this one starts from the close of 2026-10-27.
Kronos forecasts for similar companies
- BRKRP — Bruker Corporation 6.375% Mandatory Convertible Preferred Stock Series A
- A — Agilent Technologies Inc.
- WAT — Waters Corporation
- MTD — Mettler-Toledo International Inc.
- RVTY — Revvity Inc.
- AVTR — Avantor Inc.